NEONC TECHNOLOGIES HOLDINGS, INC. - 8-K Filing
NeOnc scheduled to meet with FDA on November 17, 2026 for End-of-Phase 1 Type B meeting regarding NEO212 (Items: 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)
Tickers: $NTHI
NeOnc scheduled to meet with FDA on November 17, 2026 for End-of-Phase 1 Type B meeting regarding NEO212 (Items: 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)
Tickers: $NTHI